| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Harrison M Bains Jr. last filed a Form 4 in June 2023, as Director at TVRD. Harrison M Bains Jr.'s net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 57,438 shares of TVRD. The TVRD filings lean toward selling, a net 7,200 shares.
Harrison M Bains Jr. has 10 Form 4 filings on record from June 2015 to June 2023, all as Director at Tvardi Therapeutics (TVRD), 2015–2023.
The 15 reported transactions were 9 option or other derivative awards, 5 stock awards and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $65K.
The only open-market sale was 7,200 shares of TVRD at an average $9.05 on July 15, 2022, about $65K. Twelve months later TVRD was down 69%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2022 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 7,200 | $9.05 | $65,160.00 | -22.3% | +7.9% | -69.1% |